Evaluation of the Effects of Elderberry-Based Anthocyanin-Enriched Functional Chewing Gum on Cognitive Functions and Oral Microbiota in Older Adults: A Double-Blind, Randomized Controlled Trial
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 34
- 试验地点
- 2
- 主要终点
- Change in Cognitive Function Assessed by MoCA (Montreal Cognitive Assessment) Score
研究概览
简要总结
Globally, the aging population is increasing rapidly, leading to a dramatic rise in the prevalence of Alzheimer's disease and other types of dementia. Neurodegenerative disorders are characterized by pathological hallmarks such as β-amyloid (Aβ) plaque accumulation, tau protein aggregation, synaptic loss, and widespread neuroinflammation. These processes impair key cognitive domains including attention, memory, executive function, and orientation, hindering independent daily functioning.
Beyond cognitive decline, neurodegenerative diseases are associated with a marked deterioration in oromotor functions, such as chewing and swallowing. Mastication plays a critical role not only in digestion but also in neuro-sensory stimulation. Trigeminal nerve signaling activated by chewing enhances neurotransmitter release, boosts neurotrophic factor production (e.g., BDNF), and facilitates Aβ clearance, thereby supporting synaptic plasticity and reducing inflammation. Neuroimaging studies have shown that a higher number of functional occlusal pairs is associated with increased gray and white matter volume in regions affected early in Alzheimer's disease.
Systematic reviews have identified poor mastication and tooth loss as risk factors for cognitive decline and dementia. Mechanistically, loss of afferent input from the oral cavity-due to tooth loss, reduced chewing force, prosthetic use, or muscle atrophy-leads to reduced brain stimulation, diminished neurotrophic support, and impaired cerebral blood flow. Thus, geriatric-friendly chewing gum formulations with low elasticity and ease of chewing have been recommended.
Chewing gum is a promising vehicle for functional compounds due to its potential for transmucosal absorption and cognitive stimulation. Randomized controlled trials have shown that both active and inactive gums improve attention and reduce error rates in cognitive tasks, highlighting the beneficial effects of mastication.
Another emerging target for cognitive enhancement is the oral microbiota, a complex ecosystem of over 700 bacterial species. Dysbiosis in this ecosystem has been linked to neurological outcomes via inflammatory and neurotoxic pathways. Certain pathogens, such as Porphyromonas gingivalis, have been detected in the brains of Alzheimer's patients. Moreover, metagenomic studies have shown that reduced salivary microbial diversity correlates with poorer cognitive performance, even in young adults.
Elderberry (Sambucus nigra L.) is rich in anthocyanins (e.g., cyanidin-3-glucoside, cyanidin-3-sambubioside) with strong antioxidant and anti-inflammatory properties. Literature shows that polyphenols can be absorbed via buccal and sublingual mucosa, bypassing first-pass metabolism and providing faster systemic effects. However, the impact of anthocyanin-enriched chewing gum on oral microbiota and cognitive function has not yet been systematically investigated.
This study aims to develop and evaluate a geriatric-friendly functional chewing gum enriched with standardized elderberry anthocyanins. The intervention targets dual mechanisms-neurophysiological and microbial-to support cognitive health and balance oral microbiota in older adults.
详细描述
This study is a double-blind, randomized controlled clinical trial designed to evaluate the impact of an elderberry-based functional chewing gum on cognitive function and oral microbiota in older adults.
The chewing gum intervention contains encapsulated anthocyanins derived from Sambucus nigra L., standardized for cyanidin-3-glucoside and cyanidin-3-sambubioside content, and formulated specifically for elderly individuals. The gum is designed to be soft-textured, low in elasticity, and easy to chew. It also allows transmucosal absorption through buccal and sublingual pathways, offering a rapid delivery system for polyphenols.
The study will enroll 34 participants aged 60 and above, with mild cognitive impairment (MoCA 20-25), divided equally into intervention and placebo groups. Participants will chew one gum twice daily for 6 weeks. During the intervention, participants will follow a berry-free diet to eliminate potential confounding sources of polyphenols.
Pre- and post-intervention assessments will include:
- Cognitive performance using MoCA and Stroop Color-Word Test (TBAG form)
- Salivary analysis for flow rate, pH, antioxidant capacity (FRAP), and total phenolic content (Folin-Ciocalteu)
- Microbiota profiling via 16S rRNA sequencing (in a subsample) and culturing of S. mutans and Lactobacillus spp.
- Compliance tracking via daily chewing logs and weekly monitoring
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Double (Participant, Outcomes Assessor)
盲法说明
Participants will be randomly assigned to intervention or placebo groups using computer-generated permuted block randomization (block size = 4). Allocation sequences will be created by an independent researcher. Gums will be packaged in identical blister packs labeled with alphanumeric codes that do not reveal group assignment. Only the randomization coordinator will have access to the allocation key. Investigators and outcome assessors will be blinded throughout the study. Cognitive tests and saliva sampling will be conducted by trained staff unaware of group assignment, under standardized conditions.
入排标准
- 年龄范围
- 65 Years 至 —(Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Individuals aged 60 and over
- •Individuals with mildly reduced cognitive function using the MoCA test (MoCA score: 20-25)
- •Those with stable systemic diseases (e.g. HT, controlled DM)
- •Those with adequate dental health (≥20 natural teeth or no chewing problems with functional prosthesis)
- •Non-smokers and those who use regular medication and do not use antibiotics or antiseptic mouthwashes that could seriously affect the oral microbiota
- •Individuals who are willing to participate in the study and can give written consent
排除标准
- •Moderate to severe dementia (MoCA < 20)
- •Presence of active infection or systemic inflammatory disease
- •Temporomandibular joint disorders affecting gum chewing function
- •Use of probiotics, prebiotics, or antibiotics within the last three months
- •Known allergy to elderberry or its components
结局指标
主要结局
Change in Cognitive Function Assessed by MoCA (Montreal Cognitive Assessment) Score
时间窗: Baseline and Week 6
The MoCA score (0-30) will be used to assess global cognitive function. A higher score indicates better cognitive performance. Measurements will be taken at baseline and at 6 weeks.
Change in Cognitive Function Assessed by MoCA (Montreal Cognitive Assessment) Score
时间窗: Baseline and Week 6
The MoCA score (0-30) will be used to assess global cognitive function. A higher score indicates better cognitive performance. Measurements will be taken at baseline and at 6 weeks.
次要结局
- Change in Executive Function Assessed by Stroop Test(Baseline and Week 6)
- Change in Beta Diversity Assessed by UniFrac and Bray-Curtis Distances(Baseline and Week 6)
- Change in Alpha Diversity Assessed by Shannon Index(Baseline and Week 6)
- Change in Salivary Flow Rate(Baseline and Week 6)
- Change in Salivary pH(Baseline and Week 6)
- Change in Salivary Total Antioxidant Capacity (FRAP Method)(Baseline and Week 6)
- Change in Salivary Total Phenolic Content (Folin-Ciocalteu Method)(Baseline and Week 6)
- Change in Salivary Streptococcus mutans Count(Baseline and Week 6)
- Change in Salivary Lactobacillus spp. Count(Baseline and Week 6)
- Product Acceptability Score (Hedonic Scale)(Initial Exposure and Week 6)
- Change in Executive Function Assessed by Stroop Test(Baseline and Week 6)
- Change in Alpha Diversity Assessed by Shannon Index(Baseline and Week 6)
- Change in Beta Diversity Assessed by UniFrac and Bray-Curtis Distances(Baseline and Week 6)
- Change in Salivary Flow Rate(Baseline and Week 6)
- Change in Salivary pH(Baseline and Week 6)
- Change in Salivary Total Antioxidant Capacity (FRAP Method)(Baseline and Week 6)
- Change in Salivary Total Phenolic Content (Folin-Ciocalteu Method)(Baseline and Week 6)
- Change in Salivary Streptococcus mutans Count(Baseline and Week 6)
- Change in Salivary Lactobacillus spp. Count(Baseline and Week 6)
- Product Acceptability Score (Hedonic Scale)(Initial Exposure and Week 6)
研究者
Gul Akduman
Dr.
Burdur Mehmet Akif Ersoy University
